The SAKK
Non-Profit & Charitable Organizations · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Effingerstrasse 33, Bern, Bern, 3008, Sw...Phone Number
+41 313899191Website
www.sakk.chRevenue
$11.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About The SAKK
The Swiss Cancer Institute is a not-for-profit organization dedicated to advancing clinical cancer research in Switzerland for over 60 years. It focuses on innovative cancer treatments through clinical trials and offers support for researchers, including grants and training programs for young oncologists. The institute collaborates with major university hospitals and cancer centers to optimize cancer therapies and improve patient outcomes. Its mission is to accelerate access to evidence-based therapies for patients while promoting scientific excellence in oncology.Explore more
The SAKK Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is The SAKK your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if The SAKK has recently received funding, and reach out quickly before it becomes old news!
The SAKK, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at The SAKK
Check out if The SAKK is spiking on competitors!
Earning: See what the market has to say on The SAKK recently announced quarterly report
Click to see if The SAKK had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when The SAKK launches new products
Funding: Get notified immidiatlly once The SAKK has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
The SAKK is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
The SAKK is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about The SAKK.
The SAKK Tech Stack
The SAKK News & Media
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Present Phase 2 Data in Presurgical Breast Cancer from the completed INVINCIBLE-2 Study, and an Overview of the Ongoing Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial, INVINCIBLE-4 (SAKK 66/22), at the 2024 San Antonio Breast Cancer Symposium (SABCS)
Enrollment is ongoing and seven sites in Switzerland have been activated SHELTON, Conn. and BERN, Switzerland, Dec. 12, 2024 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and...Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Announce the First Patient Dosed in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 / SAKK 66/22)
Testing the efficacy and safety of Intensity's lead drug candidate, INT230-6, when combined with Standard-of-Care versus Standard-of-Care alone The endpoint is the change in pathological complete response rates SHELTON, Conn. and BERN, Switzerland, Oct. 31, 2024 /PRNewswire/ -- Intensity...Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for INT230-6, Intensity's Lead Drug Candidate
SHELTON, Conn., May 10, 2024 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill...
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding The SAKK
Sign Up For FreeTo access detailed company insights
The Swiss Cancer Institute is a not-for-profit organization dedicated to advancing clinical cancer research in Switzerland for over 60 years. It focuses on innovative cancer treatments through clinical trials and offers support for researchers, including grants and training programs for young oncologists. The institute collaborates with major unive... Read More
